Bullish Case: UL at $61.82 sits just below the modal Helium density zone ($61–63, peak density 0.104 at $62). Call volume runs 51% above puts, bullish risk exceeds bearish by 12%, and the Helium term structure shows front-event IV (54% on 9/26 quotes) collapsing to ~21–22% thereafter — a benign catalyst would crush front IV and support a drift toward $63–65. The McCormick-merge odds rising to 79% by end-2027 adds M&A optionality to a 3.8% yielding staples compounder.

Bearish Case: Backwardation persists: near-dated implied vol (33.2% for 9/26 market-implied) far exceeds the ~21% long-dated baseline, signaling unresolved event/tail risk. Put skew is steep (12/18 $60P at 23.8% IV, delta -0.35, heaviest volume), price is -9.5% YoY with 6.0x book, Hindustan Unilever sentiment is deteriorating, and the density curve shows a fat lower tail toward $57–60. A guidance cut, macro shock, or merger-collapse headline (Dec-2026 odds only 24%) could drive $55–58.

Potential Outcomes:

1. Base drift (40%): $60–64 over 30–60d; front IV mean-reverts from ~33% to ~21% — falsified if 9/26 IV stays >30% into October.
2. Upside catalyst (20%): Beat or McCormick-2027 progress → $64–67; front IV collapse ≥25% in 3 sessions confirms.
3. Soft results (20%): Margin/growth miss → $57–59 with put IV/OI spike.
4. Macro shock (12%): SPY -6% in 2w → $55–57, skew steepens.
5. Merger delay/collapse headline (5%): → $56–58.
6. Regulatory/brand shock (3%): Verified fines/leadership exit → <$53.

September 19, 2026